1 |
Ren W, Liang P, Ma Y, Sun Q, Pu Q, Dong L, Luo G, Mazhar M, Liu J, Wang R, Yang S. Research progress of traditional Chinese medicine against COVID-19. Biomed Pharmacother 2021;137:111310. [PMID: 33761591 DOI: 10.1016/j.biopha.2021.111310] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
|
2 |
Uwizeyimana T, Hashim HT, Kabakambira JD, Mujyarugamba JC, Dushime J, Ntacyabukura B, Ndayizeye R, Adebisi YA, Lucero-Prisno DE 3rd. Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges. J Pharm Policy Pract 2021;14:12. [PMID: 33472702 DOI: 10.1186/s40545-021-00301-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
3 |
Dound YA, Sehgal R. Preclinical Efficacy and Safety Studies of Formulation SSV-003, a Potent Anti-Viral Herbal Formulation. J Exp Pharmacol 2021;13:913-21. [PMID: 34712064 DOI: 10.2147/JEP.S310452] [Reference Citation Analysis]
|
4 |
Yan K, Rawle DJ, Le TT, Suhrbier A. Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives. Virol J 2021;18:123. [PMID: 34107996 DOI: 10.1186/s12985-021-01587-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Andryukov BG, Besednova NN, Kuznetsova TA, Fedyanina LN. Laboratory-Based Resources for COVID-19 Diagnostics: Traditional Tools and Novel Technologies. A Perspective of Personalized Medicine. J Pers Med 2021;11:42. [PMID: 33451039 DOI: 10.3390/jpm11010042] [Reference Citation Analysis]
|